Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anthonius C. Coolen
HER2-HER3 Dimer Quantification by FLIM-FRET Predicts Breast Cancer Metastatic Relapse Independently of HER2 IHC Status
Oncotarget
Oncology
Related publications
Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
HER2-Orientated Therapy in Early and Metastatic Breast Cancer
Breast Care
Surgery
Oncology
Retrospective Analysis of HER2 Therapy Interruption in Patients Responding to the Treatment in Metastatic HER2+ Breast Cancer
ESMO Open
Cancer Research
Oncology
A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy
Cancer Research
Cancer Research
Oncology
HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
Serum HER2 Levels Determined by Two Methods in Patients With Metastatic Breast Cancer
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Work Productivity Activity Impairment Loss of Patients With HER2 Metastatic Breast Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
ID3014 Evaluation of HER2 Status in Breast Cancer: Current Status and Future Directions
Biomedical Research and Therapy
Biochemistry
Medicine
Genetics
Molecular Biology
Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer
Oncotarget
Oncology
